Meghana Kesireddy

Meghana Kesireddy

Oncology | Hematology
2510 Bellevue Medical Center Drive
Suite 250
Bellevue, NE 68123

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Patient-Reported Observance of a Mediterranean Diet and Physical Activity in Patients Living with Breast Cancer: Implications for Primary Care Providers.

Patient-Reported Observance of a Mediterranean Diet and Physical Activity in Patients Living with Breast Cancer: Implications for Primary Care Providers.

Journal: Journal of primary care & community health
Published: December 23, 2025

Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Complicated by Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Clinical Course Compared With Reported Cases Worldwide.

Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Complicated by Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Clinical Course Compared With Reported Cases Worldwide.

Journal: Cureus
Published: August 14, 2025

Utility of the Diagnosis-Specific Graded Prognostic Assessment for Prognostication in Leptomeningeal Disease.

Utility of the Diagnosis-Specific Graded Prognostic Assessment for Prognostication in Leptomeningeal Disease.

Journal: Oncology (Williston Park, N.Y.)
Published: May 22, 2025

Overall Survival and Prognostic Factors in De Novo Metastatic Human Epidermal Growth Factor Receptor (HER)-2-Positive Breast Cancer: A National Cancer Database Analysis.

Overall Survival and Prognostic Factors in De Novo Metastatic Human Epidermal Growth Factor Receptor (HER)-2-Positive Breast Cancer: A National Cancer Database Analysis.

Journal: Cancers
Published: May 02, 2025

Precision therapy in metastatic breast cancer: the current landscape of molecular alteration-based therapies.

Precision therapy in metastatic breast cancer: the current landscape of molecular alteration-based therapies.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: April 08, 2025

T-DM1: a promising adjuvant therapy option for stage I HER2-positive breast cancer-interpreting ATEMPT trial results from a clinical perspective.

T-DM1: a promising adjuvant therapy option for stage I HER2-positive breast cancer-interpreting ATEMPT trial results from a clinical perspective.

Journal: Gland surgery
Published: January 19, 2025

Optimizing NCCN distress thermometer use in real-world settings: a systematic review and thematic synthesis of the literature.

Optimizing NCCN distress thermometer use in real-world settings: a systematic review and thematic synthesis of the literature.

Journal: Journal of cancer survivorship : research and practice
Published: December 25, 2024

Pregnancy-Associated Breast Cancer: Key Concepts for Optimizing Diagnosis and Treatment.

Pregnancy-Associated Breast Cancer: Key Concepts for Optimizing Diagnosis and Treatment.

Journal: JCO oncology practice
Published: November 18, 2024

A Case of Severe Thrombocytopenia, Aseptic Meningitis, and Hepatitis Caused by Trimethoprim-Sulfamethoxazole: A Triple Threat.

A Case of Severe Thrombocytopenia, Aseptic Meningitis, and Hepatitis Caused by Trimethoprim-Sulfamethoxazole: A Triple Threat.

Journal: Cureus
Published: July 31, 2024

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Journal: Nature communications
Published: June 12, 2024

Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.

Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.

Journal: Cancers
Published: April 10, 2024

A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications.

A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications.

Journal: Pharmaceutical medicine
Published: October 21, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026